Projects per year
Personal profile
Biography
Dr. Kern is a urologic oncologist in the Murtha Cancer Center at the Uniformed Services University and Walter Reed National Military Medical Center. He is the founding Director of the Testicular cancer Enterprise for Survivorship, Treatment, and Investigational Sciences “TESTIS” Program at the Murtha Cancer Center, USU. He is also the Program Director of the National Capital Consortium Walter Reed Urology Residency. Prior to completing an advanced fellowship in Urologic Oncology at Indiana University, Dr. Kern was a staff urologist , Urology Service Chief, and Director of Surgical Quality at Fort Belvoir Community Hospital (renamed Alexander T. Augusta Military Medical Center) Fort Belvoir, VA, for four years. Dr. Kern's research interests are focused on the genetics of germ cell testicular cancer, surgical treatment and management of chemotherapy-resistant testicular cancer, and survivorship. He is also interested in the surgical treatment and quality of life aspects of bladder and prostate cancer. He is board certified by the American Board of Urology and a member of the Society of Urologic Oncology, American Urological Association, and Society of Government Service Urologists. Dr Kern is a member of the Board of Directors for the Testicular Cancer Awareness Foundation.
Research interests
Education/Academic qualification
Urologic Oncology, Indiana University
1 Jul 2019 → 28 Jun 2021
Medical Doctor, Uniformed Services University of the Health Sciences
1 Jul 2005 → 28 May 2009
Biology, Bachelor, United States Air Force Academy
1 Jun 2001 → 1 Jun 2005
External positions
Member, Board of Directors, Testicular Cancer Awareness Foundation
1 Aug 2023 → 1 Aug 2029
Director, Testicular cancer Enterprise for Survivorship, Treatment, and Investigational Sciences TESTIS Program, Murtha Cancer Center, Uniformed Services University-Walter Reed
1 Sep 2022 → 13 Mar 2031
Residency Program Director, National Capital Consortium
1 Jan 2022 → 1 Jan 2028
NCR Product Line Chair, Urology, National Capital Region
1 Oct 2021 → 1 Oct 2027
Keywords
- RD Surgery
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Active
-
mi RNA 371a-3p tests for screening and diagnosis of testicular cancer
Kern, S., Bagrodia, A. & Speir, R. W.
1/09/23 → 1/09/26
Project: Research
-
General Obesity and Prostate Cancer in Relation to Abdominal Obesity and Ethnic Groups: A US Population-Based Cross-Sectional Study
Ahmed, A. E., Martin, C. B., Dahman, B., Chesnut, G. T. & Kern, S. Q., 2024, In: Research and Reports in Urology. 16, p. 235-244 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Incidence rates of bladder and kidney cancers among US military servicemen: Comparison with the rates in the general US population
Bytnar, J. A., McGlynn, K. A., Kern, S. Q., Shriver, C. D. & Zhu, K., 1 Nov 2024, In: European Journal of Cancer Prevention. 33, 6, p. 505-511 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell Tumors
Kern, S., 1 Mar 2024, In: JCO Oncology Practice. 20, 3, p. 309-310 2 p.Research output: Contribution to journal › Article › peer-review
-
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy
Tachibana, I., Alabd, A., Whaley, R. D., McFadden, J., Piroozi, A., Hassoun, R., Kern, S. Q., King, J., Adra, N., Rice, K. R., Foster, R. S., Einhorn, L. H., Cary, C. & Masterson, T. A., Sep 2023, In: Urologic Oncology: Seminars and Original Investigations. 41, 9, p. 394.e1-394.e6Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Primary Retroperitoneal Lymph Node Dissection for Stage II Seminoma: Is Surgery the New Path Forward?
Tachibana, I., Alabd, A., Tong, Y., Piroozi, A., Mahmoud, M., Kern, S. Q., Masterson, T. A., Adra, N., Foster, R. S., Hanna, N. H., Einhorn, L. H. & Cary, C., 10 Aug 2023, In: Journal of Clinical Oncology. 41, 23, p. 3930-3938 9 p.Research output: Contribution to journal › Article › peer-review
15 Scopus citations
-
NCCN Oncology Policy Summit Invited Panel Member
Sean Kern (Speaker)
6 May 2024Activity: Talk or presentation › Invited talk
-
Testicular Cancer: Military Threats and Opportunities
Sean Kern (Speaker)
20 Jan 2024Activity: Talk or presentation › Invited talk
-
Immunotherapy in Non-muscle Invasive Bladder Cancer
Sean Kern (Speaker)
20 Jan 2024Activity: Talk or presentation › Invited talk
-
Testicular Cancer Survivorship
Sean Kern (Speaker)
27 Oct 2023Activity: Talk or presentation › Invited talk
-
Management of Testicular Cancer
Sean Kern (Speaker)
16 Oct 2023Activity: Talk or presentation › Invited talk
Press/Media
-
Testicular Cancer Awareness Foundation Keeps the Ball Rolling with In-Person Conference
4/07/25
1 Media contribution
Press/Media
-
Breaking the Silence: Addressing Sexual and Reproductive Health in Cancer Care
10/07/24
1 item of Media coverage
Press/Media
-
Let’s Talk About Sexual Health and Fertility Issues Faced by People With Cancer
16/05/24
1 item of Media coverage
Press/Media
-
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People With Cancer
7/05/24
2 items of Media coverage
Press/Media
-
NCCN Policy Summit Encourages Conversation and Action on Sexual Health and Fertility Issues Faced by People with Cancer
6/05/24
117 items of Media coverage
Press/Media